These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35437160)

  • 1. Late Potential Abolition in Ventricular Tachycardia Ablation.
    Roca-Luque I; Quinto L; Sanchez-Somonte P; Garre P; Alarcón F; Zaraket F; Vazquez S; Prat-Gonzalez S; Ortiz-Perez JT; Guasch E; Tolosana JM; Arbelo E; Berruezo A; Sitges M; Brugada J; Mont L
    Am J Cardiol; 2022 Jul; 174():53-60. PubMed ID: 35437160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy: Late Potential Abolition and VT Noninducibility.
    Okubo K; Gigli L; Trevisi N; Foppoli L; Radinovic A; Bisceglia C; Frontera A; D'Angelo G; Cireddu M; Paglino G; Mazzone P; Della Bella P
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008307. PubMed ID: 32657137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia.
    Silberbauer J; Oloriz T; Maccabelli G; Tsiachris D; Baratto F; Vergara P; Mizuno H; Bisceglia C; Marzi A; Sora N; Guarracini F; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):424-35. PubMed ID: 24833642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation.
    Vergara P; Trevisi N; Ricco A; Petracca F; Baratto F; Cireddu M; Bisceglia C; Maccabelli G; Della Bella P
    J Cardiovasc Electrophysiol; 2012 Jun; 23(6):621-7. PubMed ID: 22486970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late potentials abolition reduces ventricular tachycardia recurrence after ablation especially in higher-risk patients with a chronic total occlusion in an infarct-related artery.
    Di Marco A; Oloriz Sanjuan T; Paglino G; Baratto F; Vergara P; Bisceglia C; Trevisi N; Sala S; Marzi A; Gulletta S; Cireddu M; Anguera I; Della Bella P
    J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1119-1124. PubMed ID: 29543365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matching Ablation Endpoints to Long-Term Outcome: The Prospective Multicenter Italian Ventricular Tachycardia Ablation Registry.
    Radinovic A; Peretto G; Sgarito G; Cauti FM; Castro A; Narducci ML; Mantovan R; Scaglione M; Solimene F; Scopinaro A; Tondo C; Filippini G; Bianco E; Bonso A; Calzolari V; Ferraris F; Zardini M; Piacenti M; D'Angelo G; Bosica F; Della Bella P
    JACC Clin Electrophysiol; 2023 Jun; 9(6):836-847. PubMed ID: 36752462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.
    Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P
    Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance to predict recurrences after ventricular tachycardia ablation: septal involvement, transmural channels, and left ventricular mass.
    Quinto L; Sanchez P; Alarcón F; Garre P; Zaraket F; Prat-Gonzalez S; Ortiz-Perez JT; JesúsPerea R; Guasch E; Tolosana JM; San Antonio R; Arbelo E; Sitges M; Brugada J; Berruezo A; Mont L; Roca-Luque I
    Europace; 2021 Sep; 23(9):1437-1445. PubMed ID: 34142121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, long-term results, and predictors of recurrence after complete endocardial ventricular tachycardia substrate ablation in patients with previous myocardial infarction.
    Arenal Á; Hernández J; Calvo D; Ceballos C; Atéa L; Datino T; Atienza F; González-Torrecilla E; Eídelman G; Miracle Á; Avila P; Bermejo J; Fernández-Avilés F
    Am J Cardiol; 2013 Feb; 111(4):499-505. PubMed ID: 23228925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of standard bipolar amplitude voltage thresholds to identify late potential channels in ventricular tachycardia ablation.
    Roca-Luque I; Zaraket F; Garre P; Sanchez-Somonte P; Quinto L; Borras R; Guasch E; Arbelo E; Tolosana JM; Brugada J; Mont L
    J Interv Card Electrophysiol; 2023 Jan; 66(1):15-25. PubMed ID: 35195814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation.
    Berruezo A; Fernández-Armenta J; Andreu D; Penela D; Herczku C; Evertz R; Cipolletta L; Acosta J; Borràs R; Arbelo E; Tolosana JM; Brugada J; Mont L
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):326-36. PubMed ID: 25583983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multielectrode vs. point-by-point mapping for ventricular tachycardia substrate ablation: a randomized study.
    Acosta J; Penela D; Andreu D; Cabrera M; Carlosena A; Vassanelli F; Alarcón F; Soto-Iglesias D; Korshunov V; Borras R; Linhart M; Martínez M; Fernández-Armenta J; Mont L; Berruezo A
    Europace; 2018 Mar; 20(3):512-519. PubMed ID: 28069835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroanatomical voltage and morphology characteristics in postinfarction patients undergoing ventricular tachycardia ablation: pragmatic approach favoring late potentials abolition.
    Tsiachris D; Silberbauer J; Maccabelli G; Oloriz T; Baratto F; Mizuno H; Bisceglia C; Vergara P; Marzi A; Sora N; Guarracini F; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):863-73. PubMed ID: 26022186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate characterization and catheter ablation in patients with scar-related ventricular tachycardia using ultra high-density 3-D mapping.
    Nührich JM; Kaiser L; Akbulak RÖ; Schäffer BN; Eickholt C; Schwarzl M; Kuklik P; Moser J; Jularic M; Willems S; Meyer C
    J Cardiovasc Electrophysiol; 2017 Sep; 28(9):1058-1067. PubMed ID: 28597532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping.
    Oliveira M; Cunha P; Valente B; Portugal G; Lousinha A; Pereira M; Braz M; Delgado A; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2021 Nov; 40(11):865-873. PubMed ID: 34857160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial and Endocardial Ablation Based on Channel Mapping in Patients With Ventricular Tachycardia and Chronic Chagasic Cardiomyopathy: Importance of Late Potential Mapping During Sinus Rhythm to Recognize the Critical Substrate.
    de Oliveira Dietrich C; de Oliveira Hollanda L; Cirenza C; de Paola AAV
    J Am Heart Assoc; 2022 Jan; 11(1):e021889. PubMed ID: 34927451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachycardia burden reduction after substrate ablation: Predictors of recurrence.
    Quinto L; Sanchez-Somonte P; Alarcón F; Garre P; Castillo À; San Antonio R; Borras R; Guasch E; Arbelo E; Tolosana JM; Berruezo A; Mont L; Roca-Luque I
    Heart Rhythm; 2021 Jun; 18(6):896-904. PubMed ID: 33639298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of ripple mapping for identification of slow conduction channels during ventricular tachycardia ablation in the setting of arrhythmogenic right ventricular cardiomyopathy.
    Xie S; Kubala M; Liang JJ; Yang J; Desjardins B; Santangeli P; van der Geest RJ; Schaller R; Riley M; Supple G; Frankel DS; Callans D; Pac EZ; Marchlinski F; Nazarian S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):366-373. PubMed ID: 30575168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
    Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of New Technologies and Approaches for Post-Myocardial Infarction Ventricular Tachycardia Ablation During Long-Term Follow-Up.
    Yamashita S; Cochet H; Sacher F; Mahida S; Berte B; Hooks D; Sellal JM; Al Jefairi N; Frontera A; Komatsu Y; Lim HS; Amraoui S; Denis A; Derval N; Sermesant M; Laurent F; Hocini M; Haïssaguerre M; Montaudon M; Jaïs P
    Circ Arrhythm Electrophysiol; 2016 Jul; 9(7):. PubMed ID: 27406604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.